Akut mieloid leukémia (AML): vizsgálatok itt: Spanyolország
62 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisFelfüggesztveAB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Alicante, Cáceres, Madrid, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- AB Science
See details and how to joinNCT05211570 · EU 2024-516641-39-00 - 1/2. fázisNot yet taking people in SpanyolországAn Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 143 worldwide
- Run by
- Advesya SAS
See details and how to joinNCT06281847 - 1/2. fázisBefejeződöttClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Alicante, Barcelona, Madrid, Oviedo, Pozuelo de Alarcón, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00 - 3. fázisNot yet taking people in SpanyolországIvosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
- Where
- Barcelona, Girona, Valencia
- Életkor
- 18 év and over
- People
- 227 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07075016 - 2. fázisTaking peopleCHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Where
- Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Murcia, Oviedo, Palma, Santander, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- Életkor
- 1 hónap to 18 év
- People
- 60 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01 - 3. fázisTaking peopleA Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction
- Where
- Albacete, Alicante, Badalona, Cáceres, Córdoba, Madrid, Sevilla, Terrassa, Valencia
- Életkor
- 70 év and over
- People
- 262 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07082452 · EU 2025-521634-29-00 - 3. fázisNot yet taking people in SpanyolországStudying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
- Where
- Madrid
- Életkor
- Up to 18 év
- People
- 170 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT05477589 - 3. fázisTaking peopleNOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years
- Where
- Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Murcia, Palma, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- Életkor
- Up to 64 év
- People
- 730 worldwide
- Run by
- Vaestra Goetalandsregionen
See details and how to joinNCT01828489 · EU 2024-518254-16-00 - 1/2. fázisNot yet taking people in SpanyolországAn adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerability, and clinical activity in patients with relapsed/refractory acute myeloid leukaemia (RESOLVE AML 001)
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 61 worldwide
- Run by
- CanCell Therapeutics
See details and how to join2023-506865-71-00 - 2. fázisNot yet taking people in SpanyolországTMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Where
- Seville
- Életkor
- 18 év to 50 év
- People
- 58
- Run by
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT06598969 - 2. fázisTaking peopleTMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
- Where
- Sevilla
- Életkor
- 50 év to 99 év
- People
- 34
- Run by
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT06602323 · EU 2024-514483-11-00 - 2. fázisNot yet taking people in SpanyolországTreatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
- Where
- Valencia
- Életkor
- Up to 18 év
- People
- 89 worldwide
- Run by
- Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00